ERBB2 and breast carcinoma: Based on the graphical interpretation of HER2 amplification patterns—categorized as either biphasic or monophasic—HER2-positive breast carcinomas were stratified into high heterogeneity (HH) and low heterogeneity (LH) cohorts.